HACKENSACK, N.J.--(BUSINESS WIRE)--Progenitor Cell Therapy, LLC, a leading full-service provider for the contract development and manufacture of cell therapies, and Invitrogen Corporation (Nasdaq:IVGN), a global leader in life sciences, today announced they have entered into a strategic comarketing and development relationship.
